132 related articles for article (PubMed ID: 24684490)
1. Sonication-assisted drug encapsulation in layer-by-layer self-assembled gelatin-poly (styrenesulfonate) polyelectrolyte nanocapsules: process optimization.
Pandey AP; Singh SS; Patil GB; Patil PO; Bhavsar CJ; Deshmukh PK
Artif Cells Nanomed Biotechnol; 2015; 43(6):413-24. PubMed ID: 24684490
[TBL] [Abstract][Full Text] [Related]
2. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
[TBL] [Abstract][Full Text] [Related]
3. Influence of dicephalic ionic surfactant interactions with oppositely charged polyelectrolyte upon the in vitro dye release from oil core nanocapsules.
Bazylińska U; Skrzela R; Piotrowski M; Szczepanowicz K; Warszyński P; Wilk KA
Bioelectrochemistry; 2012 Oct; 87():147-53. PubMed ID: 22112718
[TBL] [Abstract][Full Text] [Related]
4. Hollow chitosan/alginate nanocapsules for bioactive compound delivery.
Rivera MC; Pinheiro AC; Bourbon AI; Cerqueira MA; Vicente AA
Int J Biol Macromol; 2015 Aug; 79():95-102. PubMed ID: 25907011
[TBL] [Abstract][Full Text] [Related]
5. Sonication-Assisted Layer-by-Layer Assembly for Low Solubility Drug Nanoformulation.
Santos AC; Pattekari P; Jesus S; Veiga F; Lvov Y; Ribeiro AJ
ACS Appl Mater Interfaces; 2015 Jun; 7(22):11972-83. PubMed ID: 25985366
[TBL] [Abstract][Full Text] [Related]
6. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
7. Functionalized photosensitive gelatin nanoparticles for drug delivery application.
Carvalho JA; da Silva Abreu A; Tedesco AC; Junior MB; Simioni AR
J Biomater Sci Polym Ed; 2019 May; 30(7):508-525. PubMed ID: 30776983
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
[TBL] [Abstract][Full Text] [Related]
9. Reversible polyelectrolyte capsules as carriers for protein delivery.
Anandhakumar S; Nagaraja V; Raichur AM
Colloids Surf B Biointerfaces; 2010 Jul; 78(2):266-74. PubMed ID: 20400274
[TBL] [Abstract][Full Text] [Related]
10. A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.
Marto J; Gouveia LF; Gonçalves LM; Gaspar DP; Pinto P; Carvalho FA; Oliveira E; Ribeiro HM; Almeida AJ
Colloids Surf B Biointerfaces; 2016 Jul; 143():177-185. PubMed ID: 27003468
[TBL] [Abstract][Full Text] [Related]
11. New method and characterization of self-assembled gelatin-oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction.
Park C; Vo CL; Kang T; Oh E; Lee BJ
Eur J Pharm Biopharm; 2015 Jan; 89():365-73. PubMed ID: 25536111
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
Karataş A; Bekmezci S
Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
[TBL] [Abstract][Full Text] [Related]
14. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
El-Habashy SE; Allam AN; El-Kamel AH
Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
[TBL] [Abstract][Full Text] [Related]
15. Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release.
Curcio M; Gianfranco Spizzirri U; Iemma F; Puoci F; Cirillo G; Parisi OI; Picci N
Eur J Pharm Biopharm; 2010 Sep; 76(1):48-55. PubMed ID: 20580821
[TBL] [Abstract][Full Text] [Related]
16. Tri/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation.
Salama AH; Shamma RN
Int J Pharm; 2015 Aug; 492(1-2):28-39. PubMed ID: 26151106
[TBL] [Abstract][Full Text] [Related]
17. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Ruparelia K
Int J Pharm; 2014 Feb; 462(1-2):83-102. PubMed ID: 24378327
[TBL] [Abstract][Full Text] [Related]
18. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
Kumbhar D; Wavikar P; Vavia P
AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
[TBL] [Abstract][Full Text] [Related]
19. Layer-by-layer engineered nanocapsules of curcumin with improved cell activity.
Kittitheeranun P; Sajomsang W; Phanpee S; Treetong A; Wutikhun T; Suktham K; Puttipipatkhachorn S; Ruktanonchai UR
Int J Pharm; 2015 Aug; 492(1-2):92-102. PubMed ID: 26143232
[TBL] [Abstract][Full Text] [Related]
20. Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations.
Zhao L; Mustapha O; Shafique S; Jamshaid T; Din FU; Mehmood Y; Anwer K; Yousafi QUA; Hussain T; Khan IU; Ghori MU; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():8819-8828. PubMed ID: 33204090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
